University of California, Irvine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Irvine sits in the top decile of US sponsors by registered trial count (#96 of 15,742 sponsors by registered trial count).
University of California, Irvine: 368 sponsored US clinical trials, 74 recruiting.
University of California, Irvine sponsors 368 registered US clinical trials on ClinicalTrials.gov, 74 of them currently recruiting, and 228 completed. 27 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 6 trials.
Top-decile sponsor footprint
University of California, Irvine ranks in the top decile of sponsors by registered trial count (#96 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
228 of 258 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
368 total, page 4 of 8
The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase
NCT03907436
Enhancing Memory Consolidation in Older Adults
NCT03657212
Long-term Telerehabilitation for Patients With Stroke
NCT03460587
Screening TO Prevent ColoRectal Cancer (STOP CRC) Among At-Risk Chinese and Korean American Primary Care Patients
NCT03481296
Wearable Device for Motivating Hand Use After Stroke
NCT03084705
Comparison of Different Ventilator and Vaporizer Technologies to Study Economic and Environmental Implications
NCT04851314
Fecal Microbiota Transplantation for the Treatment of Recurrent Urinary Tract Infections
NCT03050515
Energy Devices for Rejuvenation
NCT03767972
Dietary Approaches for Cardiometabolic Health
NCT03527290
Postoperative Opioid Consumption After Urogyneocologic Surgery
NCT03586219
Ethnic Influences on Stress, Energy Balance and Obesity in Adolescents
NCT03369691
Prevention of Adolescent Risky Behaviors: Neural Markers of Intervention Effects
NCT03370393
The Utility of Platelet Rich Plasma in Hair Loss
NCT03376581
Maternal Emotions and Diet in Pregnancy
NCT03278392
Fractional Photothermolysis for Hair Follicle Induction
NCT03382184
Functional Effects of Botox on the Brain Using MRS and fMRI
NCT03373162
Evaluating the Efficacy of the Melanocyte Keratinocyte Transplantation Procedure in the Treatment of Vitiligo
NCT04374435
Nicotinamide as an Early Alzheimer's Disease Treatment
NCT03061474
Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment
NCT03229889
Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease
NCT03515213
Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization
NCT03118232
Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population
NCT03055767
Emotional Response in Psychiatric and Control Participants
NCT03056781
Efficacy Study of the LARA Wheelchair System for Subacute Stroke Patients
NCT02830893
Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor
NCT03129945
HOPE Social Media Intervention for HIV Testing and Studying Social Networks
NCT02944877
Improving Dental Care and Oral Health in Children With Autism Spectrum Disorder
NCT03003221
Physical Exercise to Reduce Anxiety in Underserved Children With ASD
NCT02902952
Twitter-enabled Mobile Messaging for Smoking Relapse Prevention (Tweet2Quit)
NCT02823028
Gas Exchange Kinetics and Work Load During Exercise
NCT03770507
Safety and Effectiveness of Resistance Exercise Training in Patients With Pompe Disease.
NCT02654886
Telerehabilitation in the Home Versus Therapy In-Clinic for Patients With Stroke
NCT02360488
Assessing the Effects of Tretinoin Cream on Human Skin With Optical Imaging Technologies
NCT02410980
Investigating Pompe Prevalence in Neuromuscular Medicine Academic Practices
NCT02838368
Immune-Related Trafficking and Signaling in Human Skin Associated With Low-Power, Infrared Laser Treatment
NCT02453113
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS
NCT02550561
Predicting Neoadjuvant Chemotherapy Response by Using a Combined MRI and Scinti-Mammography (MRI-SMM) System
NCT02690805
Study of Daylight Photodynamic Therapy With Aminolevulinic Acid for Actinic Keratoses
NCT03327831
Efficacy Study of the Music Glove Patients With Spinal Cord Injuries
NCT02473614
Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?
NCT02276495
The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication Adherence
NCT02324036
Ovarian Cancer Patient-Centered Decision Aid
NCT02259699
A Comparison of BNP Levels Using the Nexfin Device in Healthy Pregnant and Preeclamptic Women
NCT02527018
A Clinical and Imaging Study to Evaluate a Novel Dentifrice
NCT02271815
Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes
NCT02123082
Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT02199171
Comparing Pleth Variability Index (PVI) Measurements at Different Sensing Locations
NCT02124551
Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection
NCT02326636
Active Bathing to Eliminate Infection (ABATE Infection) Trial
NCT02063867
Patient Centered Quality Reporting
NCT02738320
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 46 |
| Phase 2 | 46 |
| Phase 3 | 6 |
| Phase 4 | 21 |
Therapeutic Areas
What is open in the University of California, Irvine pipeline
74 recruiting of 368 indexed (20% open); 228 completed (62%).
Phase mix: 27 late (III/IV) vs 92 early (I/II) (early-phase heavy).
Top condition: Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Irvine: open-pipeline peers nationwide
Peers matched on 368 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of California, Irvine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 368 trials (± recruiting share)
- Northwell Health · 370 trials · 22% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
- New York State Psychiatric Institute · 364 trials · 3% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of Miami · 20% recruiting · 721 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of California, Irvine page
368 registered trials is a research-attention snapshot, not an endorsement of University of California, Irvine or any single study.
- 74 of University of California, Irvine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of California, Irvine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Irvine pipeline card: 368 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.